COMMUNIQUÉS West-GlobeNewswire

-
Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy
03/12/2018 -
Diversicare Completes Sale of Three Skilled Nursing Facilities in Kentucky
03/12/2018 -
Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources
03/12/2018 -
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/12/2018 -
Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy
03/12/2018 -
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA®
03/12/2018 -
Paratek Pharmaceuticals Files Two Patent Term Extensions in the United States; Expects NUZYRA™ Patent Protection Exclusivity Until at Least October 2030
03/12/2018 -
University Medical Centre Groningen chooses TAT-5000 of Exergen Medical as standard thermometer throughout hospital
03/12/2018 -
Nextech and Red Spot Interactive Partner to Enhance Provider Retention and Patient Acquisition
03/12/2018 -
INNATE PHARMA : Updated results that support advancement of IPH4102 in refractory Sézary syndrome at ASH 2018
03/12/2018 -
INNATE PHARMA : ASH, présentation de résultats d'IPH4102 chez les patients présentant un syndrome de Sézary réfractaire et poursuite du développement en phase II dans les lymphomes de type T
03/12/2018 -
BeiGene Presents Clinical Results of Tislelizumab in Relapsed/Refractory Classical Hodgkin’s Lymphoma at the 60th American Society of Hematology Annual Meeting
03/12/2018 -
Hybrigenics (ALHYG) : Moonstone Investments a soumis une proposition de transaction, sous conditions suspensives.
03/12/2018 -
CAPS® Teams with Kit Check to Add Serialized Radio Frequency Identification (RFID) Tags on Pre-Filled Syringes
03/12/2018 -
Exeter Hospital joins North American Partners in Anesthesia
03/12/2018 -
Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at ASH
03/12/2018 -
Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
03/12/2018 -
NICOX : Number of voting rights as of November 30. 2018
03/12/2018 -
NICOX : Nombre de droits de vote au 30 novembre 2018
03/12/2018
Pages